Stay updated on ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.2, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-20T08:36:02.000Z thumbnail image
  2. Check
    15 days ago
    No Change Detected
  3. Check
    29 days ago
    Change Detected
    Summary
    403 Forbidden error page now appears on the study page, replacing the detailed study content. This reflects a blockage of access rather than a substantive update to the study information.
    Difference
    17%
    Check dated 2026-09-22T12:24:44.000Z thumbnail image
  4. Check
    51 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.6, replacing v3.6.5. This indicates a small update to the page template or backend without changes to the study details.
    Difference
    0.1%
    Check dated 2026-08-31T23:31:03.000Z thumbnail image
  5. Check
    72 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.4 to v3.6.5, indicating a small backend or frontend update to the study page without affecting its content.
    Difference
    0.1%
    Check dated 2026-08-10T14:20:20.000Z thumbnail image
  6. Check
    87 days ago
    Change Detected
    Summary
    Revision: v3.6.4 has been added, replacing the prior Revision: v3.6.3. This indicates a software/template update for the page rather than a modification to the study data or displayed content.
    Difference
    0.1%
    Check dated 2026-07-27T06:18:39.000Z thumbnail image
  7. Check
    108 days ago
    Change Detected
    Summary
    The page's release version was updated from v3.6.2 to v3.6.3, indicating a minor maintenance update to the ClinicalTrials.gov entry without changes to study data or eligibility.
    Difference
    0.1%
    Check dated 2026-07-05T13:29:59.000Z thumbnail image

Stay in the know with updates to ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page.